Texto: 
Standard treatment: ABVD w/XRT
Adriamycin [doxorubicin], Bleomycin, Vinblastine, Dacarbazine

Prognosis is good, especially for young pts with early-stage disease 5 year survival rate of 90%
‚Ä¢ Anterior (superior) mediastinal mass, surrounding the great vessels and aortic arch.
Nodular Sclerosing Hodgkin‚Äôs Lymphoma
Mediastinal Mass:
‚Ä¢ Thymoma 
- Most common 1¬∞ anterior mediastinal mass (20%)
‚Ä¢ Lymphoma
‚Ä¢ Germ Cell Tumors
‚Ä¢ Mediastinal Cysts
‚Ä¢ Pericardial, Bronchogenic, Enteric, Thymic
‚Ä¢ Aneurysm of Ascending Aorta
‚Ä¢ Thyroid/Parathyroid Tissue
A previously healthy 23 y/o woman presents with a 4-month history of itchy skin, night sweats, and a 20-lb unintentional weight loss.
‚Ä¢ Signs & Symptoms
Often asymptomatic 
Most common = painless lymphadenopathy
1/3 of pts present w/systemic symptoms
Fatigue, generalized pruritis, ‚ÄúB‚Äù symptoms [low-grade fever, night sweats, weight loss]
Mediastinal masses may also produce mass effects

‚Ä¢ Subtypes
Nodular Sclerosing
Mixed Cellularity 
Lymphocyte-Depleted
Lymphocyte-Rich
Nodular Lymphocyte-Predominant

‚Ä¢ Nodular Sclerosing Subtype
Most common subtype in the US
Affects females > males
Median age of onset = mid-20‚Äôs

‚Ä¢ Bimodal peak distribution of onset 
Young adults (15-35) and late adulthood (>55)
Associated with EBV and HIV

http://www.uptodate.com/contents/anterior-mediastinal-mass-lesions
http://emedicine.medscape.com/article/201886-overview


Keywords: 
\-\ mediastinal\\ masses\\ may\\ also\\ produce\\ mass\\ effects\\ \\‚\\Ä\\¢\\ subtypes\\ nodular\\ sclerosing\\ mixed\\ cellularity\\ lymphocyte\ \(0\)\
\-\ 20\\ \\%\\)\\ \\‚\\Ä\\¢\\ lymphoma\\ \\‚\\Ä\\¢\\ germ\\ cell\\ tumors\\ \\‚\\Ä\\¢\\ mediastinal\\ cysts\\ \\‚\\Ä\\¢\\ pericardial\ \(0\)\
\-\ stage\\ disease\\ 5\\ year\\ survival\\ rate\ \(1\)\
\-\ predominant\\ \\‚\\Ä\\¢\\ nodular\\ sclerosing\\ subtype\ \(0\)\
\-\ common\\ 1\\ \\¬\\∞\\ anterior\\ mediastinal\\ mass\ \(0\)\
\-\ nodular\\ sclerosing\\ hodgkin\\ \\‚\\Ä\\ô\ \(0\)\
\-\ lymphoma\\ mediastinal\\ mass\ \(0\)\
\-\ \\‚\\Ä\\¢\\ bimodal\\ peak\\ distribution\ \(0\)\
\-\ ascending\\ aorta\\ \\‚\\Ä\\¢\\ thyroid\ \(0\)\
\-\ lesions\\ http\\ \\:\\/\\/\\ emedicine\ \(0\)\
\-\ late\\ adulthood\\ \\(\\>\\ 55\ \(0\)\
\-\ hiv\\ http\\ \\:\\/\\/\\ www\ \(0\)\
\-\ rich\\ nodular\\ lymphocyte\ \(0\)\
\-\ \\‚\\Ä\\ú\\ b\\ \\‚\\Ä\\ù\\ symptoms\ \(0\)\
\-\ lb\\ unintentional\\ weight\\ loss\ \(1\)\
\-\ thymic\\ \\‚\\Ä\\¢\\ aneurysm\ \(0\)\
\-\ mediastinal\\ mass\ \(75\)\
\-\ painless\\ lymphadenopathy\\ 1\ \(0\)\
\-\ \\‚\\Ä\\¢\\ anterior\ \(1\)\
\-\ systemic\\ symptoms\\ fatigue\ \(0\)\
\-\ symptoms\\ often\\ asymptomatic\ \(0\)\
\-\ \\‚\\Ä\\¢\\ thymoma\ \(0\)\
\-\ \\‚\\Ä\\¢\\ signs\ \(0\)\
\-\ us\\ affects\\ females\ \(0\)\
\-\ previously\\ healthy\\ 23\ \(1\)\
\-\ males\\ median\\ age\ \(0\)\
\-\ doxorubicin\\ \\]\\,\\ bleomycin\ \(0\)\
\-\ depleted\\ lymphocyte\ \(0\)\
\-\ 20\\ \\‚\\Ä\\ô\ \(0\)\
\-\ pts\\ present\\ w\ \(1\)\
\-\ onset\\ young\\ adults\ \(0\)\
\-\ mediastinal\ \(272\)\
\-\ common\\ subtype\ \(9\)\
\-\ weight\\ loss\ \(185\)\
\-\ 20\ \(2416\)\
\-\ mass\ \(4930\)\
\-\ young\\ pts\ \(1\)\
\-\ abvd\\ w\ \(0\)\
\-\ xrt\\ adriamycin\ \(0\)\
\-\ woman\\ presents\ \(116\)\
\-\ standard\\ treatment\ \(2\)\
\-\ parathyroid\\ tissue\ \(9\)\
\-\ night\\ sweats\ \(53\)\
\-\ month\\ history\ \(157\)\
\-\ itchy\\ skin\ \(1\)\
\-\ great\\ vessels\ \(19\)\
\-\ grade\\ fever\ \(34\)\
\-\ generalized\\ pruritis\ \(1\)\
\-\ dacarbazine\\ prognosis\ \(0\)\
\-\ aortic\\ arch\ \(157\)\
\-\ common\ \(1495\)\
\-\ anterior\ \(1277\)\
\-\ onset\ \(516\)\
\-\ vinblastine\ \(2\)\
\-\ uptodate\ \(20\)\
\-\ surrounding\ \(457\)\
\-\ superior\ \(617\)\
\-\ overview\ \(26\)\
\-\ mid\ \(1435\)\
\-\ medscape\ \(38\)\
\-\ low\ \(6512\)\
\-\ good\ \(184\)\
\-\ especially\ \(223\)\
\-\ enteric\ \(324\)\
\-\ ebv\ \(1\)\
\-\ early\ \(503\)\
\-\ contents\ \(70\)\
\-\ com\ \(7981\)\
\-\ bronchogenic\ \(40\)\
\-\ associated\ \(1240\)\
\-\ article\ \(92\)\
\-\ 90\ \(326\)\
\-\ 4\ \(7367\)\
\-\ 35\ \(305\)\
\-\ 3\ \(8405\)\
\-\ 201886\ \(1\)\
\-\ 15\ \(862\)\
